How to improve effectiveness of pegvisomant treatment in acromegalic patients
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How to improve effectiveness of pegvisomant treatment in acromegalic patients
Authors
Keywords
Acromegaly, Pegvisomant, IGF-1, Pituitary, Resistance
Journal
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 41, Issue 5, Pages 575-581
Publisher
Springer Nature
Online
2017-10-28
DOI
10.1007/s40618-017-0773-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment with high doses of pegvisomant in 56 patients with acromegaly: experience from ACROSTUDY
- (2016) Aart Jan van der Lely et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pegvisomant treatment in patients with acromegaly in clinical practice: The French ACROSTUDY
- (2015) Philippe Chanson et al. ANNALES D ENDOCRINOLOGIE
- Prediction of therapy response in acromegalic patients under pegvisomant therapy within the German ACROSTUDY cohort
- (2015) Caroline Sievers et al. Pituitary
- Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY
- (2015) I. Bernabeu et al. Pituitary
- Does pegvisomant treatment expertise improve control of resistant acromegaly? The Italian ACROSTUDY experience
- (2015) S. Cannavo et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Therapy of acromegalic patients exacerbated by concomitant type 2 diabetes requires higher pegvisomant doses to normalise IGF1 levels
- (2014) Michael Droste et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults
- (2014) A. Giustina et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Expert consensus document: A consensus on the medical treatment of acromegaly
- (2014) Andrea Giustina et al. Nature Reviews Endocrinology
- Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline
- (2014) A. Giustina et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients
- (2013) M Filopanti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Long-Term Safety of Pegvisomant in Patients with Acromegaly: Comprehensive Review of 1288 Subjects in ACROSTUDY
- (2012) A. J. van der Lely et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Surgery and Radiosurgery for Acromegaly: A Review of Indications, Operative Techniques, Outcomes, and Complications
- (2012) Yvette Marquez et al. International Journal of Endocrinology
- Influence of pegvisomant on serum ghrelin and leptin levels in acromegalic patients
- (2010) J Roemmler et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly
- (2009) Peter J. Trainer et al. CLINICAL ENDOCRINOLOGY
- Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy
- (2009) Mónica Marazuela et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study
- (2009) M Buchfelder et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- ACROSTUDY: the first 5 years
- (2009) Peter J Trainer EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Guidelines for Acromegaly Management: An Update
- (2009) S. Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly pathogenesis and treatment
- (2009) Shlomo Melmed JOURNAL OF CLINICAL INVESTIGATION
- Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review
- (2009) Gherardo Mazziotti et al. Pituitary
- A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
- (2008) I M Holdaway et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Long-term effects of pegvisomant in patients with acromegaly
- (2008) Israel Hodish et al. Nature clinical practice. Endocrinology & metabolism
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started